4 completed, 2 active not recruiting, 2 recruiting, 2 terminated. 13 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 4, Active not recruiting 2, Recruiting 2, Terminated 2, Unknown 2, Withdrawn 1 |
| Phase 1 | 2 | Active not recruiting 1, Terminated 1 |
| Phase 3 | 2 | Unknown 2 |
Follow Pancrelipase: new trials by email Literature Review of Pancrelipase trials Research Report on Pancrelipase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency. NHS7108, Zenpep® - Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF) | Phase 2 | Recruiting | Aimmune Nestlé Health Science US R&D, LLC | 66 | 2026-10-01 | 2026-10-01 |
| Phase 2 Study to Assess the Safety and Efficacy of ANG003 ANG003 Dose A, ANG003 Dose B, Creon - Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF) | Phase 2 | Recruiting | Anagram Therapeutics, Inc. | 113 | 2026-04-24 | 2026-10-30 |
| Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) Pertzye - Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 17 | 2022-11-30 | 2026-02-25 |
| Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children Pancreatic Enzyme, Ursodeoxycholic acid, Pancreatic Enzyme placebo - SEPSIS, MALNUTRITION, CHILD | Phase 2 / Phase 3 | Unknown | University of Oxford | 400 | 2021-07-01 | 2023-02-24 |
| Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency Pancrelipase - Pancreatic Adenocarcinoma | Phase 2 | Active not recruiting | Andrew Hendifar, MD | 36 | 2020-12-17 | 2026-01-23 |
| Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma Pancrelipase - Pancreatic Cancer | Phase 2 | Terminated | Dana-Farber Cancer Institute | 4 | 2018-04-13 | 2020-08-03 |
| Use of Pancreatic Enzymes in Short Bowel Syndrome Pancreatic Enzyme - Short Bowel Syndrome | Phase 2 | Completed | Children's Hospital of Philadelphia | 16 | 2017-03-24 | 2020-03-20 |
| PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer Pancrelipase, Placebo Oral Capsule - Pancreatic Insufficiency, Pancreatic Cancer | Phase 1 / Phase 2 | Terminated | Massimo Raimondo, M.D. | 16 | 2016-12-01 | 2021-03-15 |
| Fat Malabsorption in Chronic Pancreatitis Creon36™ - Chronic Pancreatitis | Phase 2 | Completed | Children's Hospital of Philadelphia | 48 | 2016-10-13 | 2019-05-03 |
| Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis Pancrelipase, placebo - Pancreatitis | Phase 2 | Withdrawn | Dartmouth-Hitchcock Medical Center | 2016-04-01 | 2018-02-27 | |
| Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Creon IR, Creon® (DR/GR) - Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis | Phase 2 | Completed | Abbott | 70 | 2015-03-01 | 2016-04-04 |
| Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency Norzyme - Bergamo, Creon - Pancreatic Insufficiency | Phase 2 / Phase 3 | Unknown | Azidus Brasil | 25 | 2010-03-01 | 2010-10-28 |
| An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI) VIOKASE 16 - Exocrine Pancreatic Insufficiency | Phase 2 | Completed | Axcan Pharma | 22 | 2008-03-01 | 2010-02-11 |
Exocrine Pancreatic Insufficiency (7) · Pancreatic Neoplasms (3) · Cystic Fibrosis (2) · Child Nutrition Disorders (1) · Dysbiosis (1) · Inflammation (1) · Malnutrition (1) · Pancreatic Diseases (1) · Pancreatitis (1) · Pancreatitis, Chronic (1) · Sepsis (1) · Short Bowel Syndrome (1)
Children's Hospital of Philadelphia (2) · Abbott (1) · Aimmune Nestlé Health Science US R&D, LLC (1) · Anagram Therapeutics, Inc. (1) · Andrew Hendifar, MD (1) · Axcan Pharma (1) · Azidus Brasil (1) · Dana-Farber Cancer Institute (1) · Dartmouth-Hitchcock Medical Center (1) · Massimo Raimondo, M.D. (1) · Memorial Sloan Kettering Cancer Center (1) · University of Oxford (1)
United States (10) · Hungary (2) · Poland (2) · Spain (2) · Bangladesh (1) · Brazil (1) · Bulgaria (1) · Czechia (1) · Italy (1) · Kenya (1) · Malawi (1) · Uganda (1) · United Kingdom (1)
Andrew Hendifar, MD, MPH (1) · Arthur James Moser, MD (1) · Babette Zemel, PhD (1) · Eileen O'Reilly, MD (1) · James A Berkley, MD (1) · Massimo Raimondo, MD (1) · Monique Bunyan (1) · Natalie Terry, MD, PhD (1) · Phillip P. Toskes, M.D. (1) · Suntje Sander-Struckmeier, PhD (1) · Timothy B Gardner, MD (1) · Virginia Stallings, MD (1)
2014 (1), 2025 (1)